WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2021

Aug 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2021-08-23

Reporting Person: Joseph Molly (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-23	Common Stock	A	308.00	—	Acquired	308.00	Direct

Footnotes

F1: These shares of restricted stock units will vest in full on May 3, 2022 and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.